English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Micro ribonucleic acids (mi RNA s) are a cluster of small non‐coding  RNA  molecules predicted to regulate more than 30% of coding messenger ( m)RNAs  in the human genome and proven to be essential in developmental and pathological processes. The  miR ‐182 gene was first found to be abundantly expressed in sensory organs and regulates the development of the retina and inner ear. Further studies revealed its roles in osteogenesis and T cell differentiation. In addition, the involvement of  miR ‐182 in cancer initiation and progression has recently been uncovered by a growing body of evidence, the majority of which supports its promoting effects in cell proliferation, angiogenesis, and invasion, as well as distant metastasis of various cancer types. Clinical analyses demonstrated the link of  miR ‐182 expression to poor prognosis in cancer patients. Mechanistically, multiple downstream genes including missing‐in‐metastasis, microphthalm‐associated transcription factor,  FoxO1 , cylindromatiosis, and others, can be targeted by  miR ‐182 and mediate its roles in cancer.  miR ‐182 is also interconnected with prominent cancer‐related signaling pathways, such as transforming growth factor beta and nuclear factor kappa beta. Interestingly, it was shown that  in vivo  targeting of  miR ‐182 prevented liver metastasis of melanoma.  miR ‐182 is emerging as an important regulator of malignancies, which warrants further study to establish the application potential of  miR ‐182 in cancer diagnosis and treatment.

Roles of miR‐182 in sensory organ development and cancer